Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Dr. Anton Yuryev

Dr. Anton Yuryev

Professional Services Director

Connect with Dr. Anton Yuryev on LinkedIn

About the author: Dr. Anton Yuryev has M.S degree in Physics from Moscow Institute of Physics and Technology, Russia and Ph.D in Genetics and Molecular Biology from Johns Hopkins University, USA where he discovered proteins physically linking gene transcription with mRNA processing in eukaryotic cells.  He has over 20 years of experience in bioinformatics.  After finishing his post-doctoral training at Novartis Inc Dr. Yuryev worked as Senior Scientist at InforMax, then continued at Orchid Bioscience as Senior Bioinformatics Analyst, and then as Senior Director of Application Science at Ariadne Genomics where he participated in the development of natural language processing technology and award-winning Pathway Studio software.  Dr. Yuryev has published more than 40 scientific publications, edited three scientific books, and authored several algorithms for primer design and pathway analysis.  He works now as Professional Services Director at Elsevier and responsible for development of targeted bioinformatics solutions using Elsevier software and knowledge bases for areas of drug development, personalized medicine and agrobiology.

Posts by Dr. Anton Yuryev

Five drug development strategies to combat 2019 novel coronavirus

Posted on April 15th, 2020 in COVID-19

This article was originally published on Feb 28, 2020, and has been updated on Apr 13, 2020.

Coronavirus disease 19 (COVID-19) has rapidly spread from its starting point in Wuhan, China. As of February 23, 2020, a total of 32 countries and territories have reported 78,811 cases (98% in China) and 2462 deaths [1]. The international scientific community is in a race against time. Researchers across the globe are collaborating to develop antivirals and vaccines to contain the spread of 2019 novel coronavirus (SARS-CoV-2).


Integration and visualization of COVID-19 molecular mechanisms using Pathway Studio

Posted on April 6th, 2020 in COVID-19

Integrating the rich information from multi-omics data has been a popular approach to drugs discovery and development against novel 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To facilitate the integrative analysis and power the global researchers, we have constructed various models that contain biomedical pathways information for SARS-CoV and SARS-CoV-2. Now they are available for public access.


Seeing Research Through a Scientist’s Eyes

Posted on July 26th, 2017 in Pharma R&D

If it’s your job to create and maintain information solutions designed to be used by scientists, it probably helps if you have real-world experience conducting scientific research, right? (more…)

Precise Medicines: Matching Patients with the Most Effective Drugs

Posted on July 14th, 2017 in Pharma R&D

Precision medicine is making us re-think the way we treat disease. Rather than selecting therapies based solely on the disease itself, doctors are increasingly considering the patient’s unique genomic and molecular make-up when determining treatment. (more…)

  1. 1
  2. 2